A systematic review explores how AI-based clinical decision support systems can enhance cardiovascular disease management while facing adoption and equity challenges.
Key Details
- 1Research from Flinders University reviews AI's role in cardiovascular care through CDSS.
- 2Study identifies workflow integration, usability, and workforce readiness as key barriers to adoption.
- 3Out of 700+ studies, 12 large, global studies were deeply assessed.
- 4Strong governance, organisational support, and regulatory alignment are crucial for sustainable AI implementation.
- 5AI systems could reduce diagnosis delays and improve care in underserved, rural settings.
- 6Equity issues persist due to potential dataset bias and lack of AI-integrated prevention protocols.
Why It Matters
There is significant promise for AI-driven CDSS to improve cardiovascular care management, which can inform implementation in radiology and related imaging fields. Understanding barriers to adoption, governance needs, and equity issues can help the radiology-AI community advance safe, effective, and equitable integration of AI tools.
Source
EurekAlert
Related News
•EurekAlert
AI Transforms Early Detection and Prediction in Kidney Disease
Artificial intelligence is increasingly enabling earlier detection and improved prediction of kidney disease progression by leveraging complex clinical and imaging data.
•EurekAlert
Stanford Study: Physicians Plus AI Chatbots Improve Clinical Decision-Making
Stanford-led studies show that physicians supported by AI chatbots match or exceed chatbot-alone performance in nuanced clinical decision-making.
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.